Problem viewing this email? View it in your browser.
 
 
Logo Header
Facebook Twitter LinkedIn
LinkedIn
May 11, 2022 / Dicardiology.com
Heart failure patients implanted with Barostim can now receive conditional MRI scans
CVRx Receives MR-conditional Labeling Approval for its Barostim Heart Failure System

CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has received U.S. Food and Drug Administration (FDA) approval for magnetic resonance conditional labeling for its Barostim System.

Read More
Results from the DELIVER and DAPA-HF Phase III trials demonstrate FARXIGA’s efficacy in heart failure regardless of ejection fraction
FARXIGA Met Primary Endpoint in DELIVER Phase III Trial

High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a statistically significant and clinically meaningful reduction in the primary composite endpoint of cardiovascular (CV) death or worsening heart failure (HF). 

Read More
 
 
 
The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot from a different room, a different city, or even a different country. 
WLNC Highlights Q Catheter Compatibility in Simulated Robotic Thrombectomy

The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot.

Read More
COVID-19 had a profound impact on the cardiovascular imaging system in 2020.
Cardiovascular Ultrasound Market Forecast

The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period, according to The Cardiovascular Ultrasound System Market—Growth, Trends, COVID-19 Impact and Forecast (2022-2027), a new report from Mordor Intelligence.

Read More
person looking at smart watch
Mayo Researchers Use AI to Detect Weak Heart Pump via Patients’ Apple Watch ECGs

Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.

Read More
 

Custom comparison charts

Interested in create a custom comparison chart for your specific research needs? Check out our website for more information.

 
LinkedIn
 
 
Logo Header